Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E

Repurposing vitamins as antiviral supporting agents is a rapid approach used to control emerging viral infections. Although there is considerable evidence supporting the use of vitamin supplementation in viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the sp...

Full description

Bibliographic Details
Main Authors: Yassmin Moatasim, Omnia Kutkat, Ahmed M. Osman, Mokhtar R. Gomaa, Faten Okda, Mohamed El Sayes, Mina Nabil Kamel, Mohamed Gaballah, Ahmed Mostafa, Rabeh El-Shesheny, Ghazi Kayali, Mohamed A. Ali, Ahmed Kandeil
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/11/11/2777
_version_ 1797458311289765888
author Yassmin Moatasim
Omnia Kutkat
Ahmed M. Osman
Mokhtar R. Gomaa
Faten Okda
Mohamed El Sayes
Mina Nabil Kamel
Mohamed Gaballah
Ahmed Mostafa
Rabeh El-Shesheny
Ghazi Kayali
Mohamed A. Ali
Ahmed Kandeil
author_facet Yassmin Moatasim
Omnia Kutkat
Ahmed M. Osman
Mokhtar R. Gomaa
Faten Okda
Mohamed El Sayes
Mina Nabil Kamel
Mohamed Gaballah
Ahmed Mostafa
Rabeh El-Shesheny
Ghazi Kayali
Mohamed A. Ali
Ahmed Kandeil
author_sort Yassmin Moatasim
collection DOAJ
description Repurposing vitamins as antiviral supporting agents is a rapid approach used to control emerging viral infections. Although there is considerable evidence supporting the use of vitamin supplementation in viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the specific role of each vitamin in defending against coronaviruses remains unclear. Antiviral activities of available vitamins on the infectivity and replication of human coronaviruses, namely, SARS-CoV-2, Middle East respiratory syndrome coronavirus (MERS-CoV), and human coronavirus 229E (HCoV-229E), were investigated using in silico and in vitro studies. We identified potential broad-spectrum inhibitor effects of Hydroxocobalamin and Methylcobalamin against the three tested CoVs. Cyanocobalamin could selectively affect SARS-CoV-2 but not MERS-CoV and HCoV-229E. Methylcobalamin showed significantly higher inhibition values on SARS-CoV-2 compared with Hydroxocobalamin and Cyanocobalamin, while Hydroxocobalamin showed the highest potent antiviral activity against MERS-CoV and Cyanocobalamin against HCoV-229E. Furthermore, in silico studies were performed for these promising vitamins to investigate their interaction with SARS-CoV-2, MERS-CoV, and HCoV-229E viral-specific cell receptors (ACE2, DPP4, and hAPN protein, respectively) and viral proteins (S-RBD, 3CL pro, RdRp), suggesting that Hydroxocobalamin, Methylcobalamin, and Cyanocobalamin may have significant binding affinity to these proteins. These results show that Methylcobalamin may have potential benefits for coronavirus-infected patients.
first_indexed 2024-03-09T16:35:15Z
format Article
id doaj.art-759974bd6b564de6bd096b33d6cdfb32
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-09T16:35:15Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-759974bd6b564de6bd096b33d6cdfb322023-11-24T14:57:13ZengMDPI AGMicroorganisms2076-26072023-11-011111277710.3390/microorganisms11112777Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229EYassmin Moatasim0Omnia Kutkat1Ahmed M. Osman2Mokhtar R. Gomaa3Faten Okda4Mohamed El Sayes5Mina Nabil Kamel6Mohamed Gaballah7Ahmed Mostafa8Rabeh El-Shesheny9Ghazi Kayali10Mohamed A. Ali11Ahmed Kandeil12Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptBiochemistry Department, Faculty of Science, Cairo University, Cairo 12613, EgyptCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptVeterinary Research Institute, National Research Centre, Giza 12622, EgyptCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptHuman Link, Dubai 115738, United Arab EmiratesCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, EgyptRepurposing vitamins as antiviral supporting agents is a rapid approach used to control emerging viral infections. Although there is considerable evidence supporting the use of vitamin supplementation in viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the specific role of each vitamin in defending against coronaviruses remains unclear. Antiviral activities of available vitamins on the infectivity and replication of human coronaviruses, namely, SARS-CoV-2, Middle East respiratory syndrome coronavirus (MERS-CoV), and human coronavirus 229E (HCoV-229E), were investigated using in silico and in vitro studies. We identified potential broad-spectrum inhibitor effects of Hydroxocobalamin and Methylcobalamin against the three tested CoVs. Cyanocobalamin could selectively affect SARS-CoV-2 but not MERS-CoV and HCoV-229E. Methylcobalamin showed significantly higher inhibition values on SARS-CoV-2 compared with Hydroxocobalamin and Cyanocobalamin, while Hydroxocobalamin showed the highest potent antiviral activity against MERS-CoV and Cyanocobalamin against HCoV-229E. Furthermore, in silico studies were performed for these promising vitamins to investigate their interaction with SARS-CoV-2, MERS-CoV, and HCoV-229E viral-specific cell receptors (ACE2, DPP4, and hAPN protein, respectively) and viral proteins (S-RBD, 3CL pro, RdRp), suggesting that Hydroxocobalamin, Methylcobalamin, and Cyanocobalamin may have significant binding affinity to these proteins. These results show that Methylcobalamin may have potential benefits for coronavirus-infected patients.https://www.mdpi.com/2076-2607/11/11/2777vitaminsantiviral agentvitamin B12SARS-CoV-2MERS-CoVviral infection
spellingShingle Yassmin Moatasim
Omnia Kutkat
Ahmed M. Osman
Mokhtar R. Gomaa
Faten Okda
Mohamed El Sayes
Mina Nabil Kamel
Mohamed Gaballah
Ahmed Mostafa
Rabeh El-Shesheny
Ghazi Kayali
Mohamed A. Ali
Ahmed Kandeil
Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
Microorganisms
vitamins
antiviral agent
vitamin B12
SARS-CoV-2
MERS-CoV
viral infection
title Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
title_full Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
title_fullStr Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
title_full_unstemmed Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
title_short Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
title_sort potent antiviral activity of vitamin b12 against severe acute respiratory syndrome coronavirus 2 middle east respiratory syndrome coronavirus and human coronavirus 229e
topic vitamins
antiviral agent
vitamin B12
SARS-CoV-2
MERS-CoV
viral infection
url https://www.mdpi.com/2076-2607/11/11/2777
work_keys_str_mv AT yassminmoatasim potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT omniakutkat potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT ahmedmosman potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT mokhtarrgomaa potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT fatenokda potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT mohamedelsayes potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT minanabilkamel potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT mohamedgaballah potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT ahmedmostafa potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT rabehelshesheny potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT ghazikayali potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT mohamedaali potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e
AT ahmedkandeil potentantiviralactivityofvitaminb12againstsevereacuterespiratorysyndromecoronavirus2middleeastrespiratorysyndromecoronavirusandhumancoronavirus229e